These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 213213)

  • 1. Isolation and identification of some urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM; Doonan S
    Clin Chim Acta; 1978 Oct; 89(2):273-8. PubMed ID: 213213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary inhibitor of the formation of calcium oxalate.
    Sutor DJ; Percival JM; Doonan S
    Br J Urol; 1979 Aug; 51(4):253-5. PubMed ID: 223711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assay method for the measurement of urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM
    Clin Chim Acta; 1978 Oct; 89(2):256-72. PubMed ID: 213212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.
    Costa-Bauzá A; Barceló C; Perelló J; Grases F
    Int Urol Nephrol; 2002; 34(4):447-51. PubMed ID: 14577482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory activity of some citrate analogues upon calcium crystalluria: observations using an improved urine evaporation technique.
    Hallson PC; Kasidas GP; Samuell CT
    Urol Int; 1996; 57(1):43-7. PubMed ID: 8840490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Res; 1983; 11(4):151-4. PubMed ID: 6316611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Int; 1983; 38(3):179-81. PubMed ID: 6868215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cellulose phosphate and sodium phosphate on formation product and activity product of brushite in urine.
    Pak CY
    Metabolism; 1972 May; 21(5):447-55. PubMed ID: 4335734
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary inhibitors of calcium phosphate formation: the inhibitory activity of normal and artificial urines.
    Sutor DJ; Percival JM; Piper KA
    Br J Urol; 1979 Feb; 51(1):1-5. PubMed ID: 465954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of phosphate therapy of urinary calculi].
    Kollwitz AA; Kracht H; Meier F
    Urologe; 1966 Jul; 5(4):168-71. PubMed ID: 4296919
    [No Abstract]   [Full Text] [Related]  

  • 14. Orthophosphate and other phosphate compounds in relation to stone formation.
    Fleisch H
    Adv Exp Med Biol; 1978; 103():203-16. PubMed ID: 213950
    [No Abstract]   [Full Text] [Related]  

  • 15. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High molecular weight substances which inhibit calcium oxalate crystal growth. 1: Relative potencies of various kinds of urinary inhibitors which were determined new assay method (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1334-41. PubMed ID: 215812
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities.
    Laminski NA; Meyers AM; Sonnekus MI; Smyth AE
    Nephron; 1990; 56(4):379-86. PubMed ID: 1964200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different fractions of macromolecules upon triggering of calcium oxalate and calcium phosphate crystal formation in whole urine.
    Rose GA; Sulaiman S
    Urol Int; 1984; 39(3):147-9. PubMed ID: 6740804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.